{
  "meta": {
    "title": "25_National_Health_Programmes_Iii_-_Nis_Jsy_Rbsk_And_Others",
    "url": "https://brainandscalpel.vercel.app/25-national-health-programmes-iii-nis-jsy-rbsk-and-others-dfdd2518.html",
    "scrapedAt": "2025-11-30T12:26:59.582Z"
  },
  "questions": [
    {
      "text": "A 9-month-old infant who has not been previously vaccinated is brought to the OPD. The mother is however adamant and is allowing you to inject the baby with only one vaccine. Which of the following vaccines would you choose to administer in this situation?",
      "choices": [
        {
          "id": 1,
          "text": "DPT"
        },
        {
          "id": 2,
          "text": "Measles"
        },
        {
          "id": 3,
          "text": "IPV"
        },
        {
          "id": 4,
          "text": "Pentavalent"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In this situation,&nbsp;<strong>measles vaccine</strong> should be administered subcutaneously because, at 9 months of age, it is a priority to give the measles vaccine.&nbsp;<strong>OPV and vitamin A</strong> should be given orally.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4738",
      "difficulty": "medium"
    },
    {
      "text": "An intern posted in the labour room is administering birth dose vaccines to a newborn baby. According to the National Immunization Schedule, which of the following vaccines would he not administer?<div class='question-desc-html'><ol>\n<li>OPV</li>\n<li>IPV</li>\n<li>BCG</li>\n<li>Hepatitis B</li>\n<li>Pentavalent</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, and 4"
        },
        {
          "id": 2,
          "text": "1 and 5 only"
        },
        {
          "id": 3,
          "text": "2, 4, and 5"
        },
        {
          "id": 4,
          "text": "2 and 5 only"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Inactivated Polio Vaccine (IPV) and pentavalent vaccine are not given at birth.&nbsp;The vaccines given at birth are <strong>BCG</strong>, <strong>OPV (0 dose) and hepatitis B&nbsp;</strong>vaccines.</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7985",
      "difficulty": "easy"
    },
    {
      "text": "A farmer residing in West Bengal brings his 16-month-old child to the OPD for routine immunization. The child has been adequately immunized till now and has already received a measles vaccine during a supplementary immunization activity drive a few months back. What will you administer to him now?",
      "choices": [
        {
          "id": 1,
          "text": "OPV booster, DPT booster and Vitamin A"
        },
        {
          "id": 2,
          "text": "OPV Booster, DPT booster, MR, JE and Vitamin A"
        },
        {
          "id": 3,
          "text": "OPV booster, DPT booster, JE vaccine and Vitamin A"
        },
        {
          "id": 4,
          "text": "OPV Booster, DPT booster, MR and Vitamin A"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Vaccines to be given at <strong>16 months</strong> of age are <strong>OPV booster, DPT booster, MR, JE, and Vitamin A</strong>.</p>\n<p>The child<strong> should receive routine doses</strong> of the measles vaccine according to the schedule <strong>irrespective</strong> <strong>of</strong> the measles supplementary immunisation activity (<strong>SIA</strong>) dose. So, the second dose of the measles vaccine is also given.</p>\n<p><strong>Japanese Encephalitis </strong>(JE) is endemic in rural agricultural areas, often associated with rice cultivation and flood irrigation. <strong>Vaccination</strong> for JE is given in <strong>endemic states</strong> only. Two doses of a <strong>live</strong> <strong>attenuated</strong> JE vaccine are given under the Universal Immunisation Programme (<strong>UIP</strong>) schedule. Under the Indian Academy of Pediatrics (<strong>IAP</strong>) schedule, two doses of a new <strong>vero cell-derived inactivated</strong> JE vaccine are given.</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4748",
      "difficulty": "medium"
    },
    {
      "text": "A three and a half-year-old child, who is completely unimmunized, is brought to a PHC. Which of the following vaccines can be given to the child now?",
      "choices": [
        {
          "id": 1,
          "text": "DPT-1, OPV-1  and Vit A"
        },
        {
          "id": 2,
          "text": "DT-1, OPV-1, Measles, Vit A"
        },
        {
          "id": 3,
          "text": "DPT-1, OPV-1, Measles, Vit A"
        },
        {
          "id": 4,
          "text": "BCG, DPT-1, OPV-1, Measles, Vit A"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>DPT-1, OPV-1, measles and vitamin A</strong> can be given to this child of 3.5 years of age in his first immunization visit.</p>\n<p><strong>BCG</strong> can only be given <strong>up to 1 year</strong> of age, according to the National Immunisation Schedule (<strong>NIS</strong>).&nbsp;</p>\n<p>Note: <strong>BCG</strong> can be given up to <strong>5 years</strong> of age, as part of the <strong>catch-up</strong> immunization schedule which is by the Indian Academy of Paediatrics (<strong>IAP</strong>) and is not followed in government setups.</p>\n<p><strong>OPV</strong> can be given<strong> till 5 years</strong> of age.</p>\n<p><strong>Measles</strong> can be given <strong>till 5 years</strong> of age.</p>\n<p><strong>DPT</strong> can be given&nbsp;<strong>till 7 years</strong> of age (with booster doses).</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4781",
      "difficulty": "medium"
    },
    {
      "text": "A 5-year-old girl is brought to your clinic for routine immunization. According to the National Immunisation Schedule, which of the following  would you administer?",
      "choices": [
        {
          "id": 1,
          "text": "DT booster + vitamin A"
        },
        {
          "id": 2,
          "text": "DPT booster only"
        },
        {
          "id": 3,
          "text": "DPT booster  + OPV"
        },
        {
          "id": 4,
          "text": "DPT booster  + vitamin A"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>At 5 years of age, the 2nd <strong>booster dose of DPT</strong> must be given along with the<strong> 9<sup>th</sup> (final) dose of vitamin A</strong>.</p>\n<p><strong>1st booster</strong> dose of <strong>DPT</strong> is given at <strong>16 – 24 months</strong> of age.</p>\n<p><strong>1st dose</strong> of <strong>vitamin A</strong> is given at <strong>9th month</strong> and the <strong>2nd</strong> <strong>dose</strong> is given at <strong>16 months</strong> followed by one dose every 6 months thereafter until the age of 5.</p>\n<p>Note: DPT booster + Vitamin A is a better answer than DPT booster + OPV because the 9th (final) dose of <strong>vitamin A</strong> <strong>must</strong> be given <strong>at 5 years</strong> but OPV at 5 years is an optional vaccine.</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8021",
      "difficulty": "medium"
    },
    {
      "text": "A 9-year-old child is brought to the PHC for receiving the JE vaccine. The nurse cleans the injection site with a spirit swab and injects the live attenuated JE vaccine subcutaneously on the left upper arm. Which of the following statements is true regarding this scenario?",
      "choices": [
        {
          "id": 1,
          "text": "The procedure of administering the vaccine is wrong"
        },
        {
          "id": 2,
          "text": "The site of administering the JE vaccine is inappropriate"
        },
        {
          "id": 3,
          "text": "The JE vaccine cannot be administered under routine immunization in a PHC after 2 years of age"
        },
        {
          "id": 4,
          "text": "Only live attenuated JE vaccine is currently under use"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The procedure of administration is wrong as it is not advisable to clean the injection site with a spirit swab because some of the <strong>live components</strong> of the vaccine <strong>are killed</strong> if they come <strong>in contact</strong> <strong>with</strong> <strong>spirit</strong>.</p>\n<p>The child is eligible to receive the Japanese Encephalitis (JE) vaccine through routine immunization<strong> till 15 years</strong> of age. Live attenuated JE vaccine is administered in the<strong> left upper arm subcutaneously.</strong></p>\n<p><strong>JENVAC</strong> is a new <strong>inactivated</strong> vero cell culture derived JE vaccine produced by Bharath Biotech International limited in India. It is a <strong>Kolar strain-</strong>derived vaccine. The recommended dose is <strong>0.5ml</strong> which is given intramuscularly at left anterolateral aspect of midthigh, <strong>4 weeks apart</strong> starting from 1 year of age. Although a booster dose is recommended at a later period, the appropriate time for booster dose administration is not clear.</p>\n<p><strong>JEEV</strong> is another <strong>inactivated</strong> vero cell culture derived vaccine from the <strong>SA-14-14-2 strain</strong>. The recommended dose is:     </p>\n<ul>\n<li>1-3 years: 2 doses of 0.25 ml on 0 and 28 days</li>\n<li>&gt;3years, adolescents, and adults: 2 doses of 0.5ml on 0 and 28 days</li>\n<li>A booster dose of this vaccine is suggested to be given after 12 months of primary vaccination in non-endemic areas.  </li>\n</ul>\n<p>The inactivated vaccines are currently under the recommendation of IAP. Under the Universal Immunization Programme (<strong>UIP</strong>), a <strong>live attenuated</strong> vaccine is given.</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4743",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following was launched to ensure complete immunization of children?",
      "choices": [
        {
          "id": 1,
          "text": "Mission Dhanush"
        },
        {
          "id": 2,
          "text": "Mission Indradhanush"
        },
        {
          "id": 3,
          "text": "Mission Indira Yojana"
        },
        {
          "id": 4,
          "text": "Mission Suraksha Yojana"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Mission Indradhanush</strong> was launched by the Ministry of Health and Family Welfare in 2014 to fully immunize children (&gt;90%) who are either partially immunized or completely unimmunized by 2020. It was later modified in 2017 to the Intensified Mission Indradhanush, to achieve the same goal by December 2018. </p>\n<p>Intensified Mission Indradhanush includes <strong>12 vaccine-preventable diseases</strong> (updated from the 7 diseases that Mission Indradhanush focussed on). <strong>4 rounds </strong>of immunization are proposed to be held for <strong>7 days each month</strong> (from the 7th- 13th of each month).</p>\n<p>The diseases included in <strong>Mission Indradhanush</strong> are:</p>\n<ul>\n<li>TB</li>\n<li>Polio</li>\n<li>Hep B</li>\n<li>Diphtheria</li>\n<li>Pertussis</li>\n<li>Tetanus</li>\n<li>Measles</li>\n</ul>\n<p>The diseases included recently in <strong>Intensified Mission Indradhanush</strong> are:</p>\n<ul>\n<li>Rotavirus diarrhoea</li>\n<li>Rubella (as MR vaccine)</li>\n<li>H. influenzae B diseases (as part of the pentavalent vaccine)</li>\n<li>Pneumococcal meningitis</li>\n<li>Japanese Encephalitis</li>\n</ul>\n<p>The <strong>Intensified Mission Indradhanush 2.0: </strong></p>\n<p>The government of India introduced IMI 2.0 to accelerate the vaccine drive and extend the coverage to children and pregnant women in identified districts and blocks from December 2019- March 2020.</p>\n<p><strong>Note</strong>: Currently, the government has completed <strong>Intensified Mission Indradhanush 5.0:<br /><br /></strong>Intensified Mission Indradhanush (IMI 5.0), the flagship routine immunization campaign of the <strong>Union Ministry of Health and Family Welfare</strong> concluded all 3 rounds in October 2023. This is the <strong>first campaign</strong> to be conducted across <strong>all</strong> the <strong>districts</strong> in the country and includes <strong>children up to 5 years</strong> of age (Previous campaigns included children up to 2 years of age). It also had a <strong>special focus</strong> on improvement of <strong>Measles</strong> and <strong>Rubella</strong> <strong>vaccination</strong> coverage.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/49494eecbbc049f691b0ba1854377994x647x404.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8038",
      "difficulty": "easy"
    },
    {
      "text": "You are visiting a rural area for a vaccination drive conducted under the Intensified Mission Indradhanush scheme. Which of the following vaccines would you not administer in this vaccination drive?",
      "choices": [
        {
          "id": 1,
          "text": "H. influenzae B vaccine"
        },
        {
          "id": 2,
          "text": "Rubella vaccine"
        },
        {
          "id": 3,
          "text": "Pneumococcal conjugate vaccine"
        },
        {
          "id": 4,
          "text": "Typhoid vaccine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Typhoid vaccine is not a part of the Intensified Mission Indradhanush scheme.&nbsp;</p>\n<p>The Intensified Mission Indradhanush scheme has been introduced to ensure full immunization (<strong>&gt;90%</strong>) by&nbsp;December 2018. It now includes <strong>12 vaccine-preventable diseases </strong>(VPDs) (updated from the 7 that Mission Indradhanush focussed on). <strong>4 rounds of immunization</strong> are proposed to be held for <strong>7 days each month</strong> (from the 7th-13th of each month).</p>\n<p>The diseases included in <strong>Mission Indradhanush</strong> are:</p>\n<ul>\n<li>TB</li>\n<li>Polio</li>\n<li>Hep B</li>\n<li>Diphtheria</li>\n<li>Pertussis</li>\n<li>Tetanus</li>\n<li>Measles</li>\n</ul>\n<p>The diseases included recently in <strong>Intensified Mission Indradhanush</strong> are:</p>\n<ul>\n<li><strong>Rotavirus </strong>diarrhoea</li>\n<li><strong>Rubella </strong>(as MR vaccine)</li>\n<li><strong>H. influenzae B </strong>diseases (as part of the pentavalent vaccine)</li>\n<li><strong>Pneumococcal meningitis</strong></li>\n<li><strong>Japanese Encephalitis</strong></li>\n</ul>\n<p>The purpose of Intensified Mission Indradhanush (IMI) is to reach each and every child<strong> under 2 years </strong>of age and all those <strong>pregnant</strong> <strong>women</strong> who have been left uncovered under the routine immunization coverage.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e35e514a661e4827be330f58fad8e4fcx647x404.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4775",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is correct regarding the National Deworming Programme?",
      "choices": [
        {
          "id": 1,
          "text": "It is conducted in the months of March and September"
        },
        {
          "id": 2,
          "text": "Free tablets are given to children up to the age of 15 years"
        },
        {
          "id": 3,
          "text": "It is carried out in schools and anganwadis"
        },
        {
          "id": 4,
          "text": "Age appropriate dose of tablet metronidazole is recommended"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The National Deworming programme is carried out in <strong>schools and anganwadis.</strong></p>\n<p>It is conducted<strong> twice a year</strong>, in the months of<strong> February and August</strong>,&nbsp;covering all the children from&nbsp;the age of<strong> 1 to 19 years</strong>.&nbsp;All the children are given age-appropriate dose of tablet <strong>albendazole</strong>.</p>\n<p>In the states of Rajasthan and Madhya Pradesh, it is carried out only once a year (as the prevalence is &lt;20% in these states).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4733",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke?",
      "choices": [
        {
          "id": 1,
          "text": "No separate centres for stroke, DM and cancer"
        },
        {
          "id": 2,
          "text": "Implementation in over 10 districts in 5 states"
        },
        {
          "id": 3,
          "text": "District hospital has specialized facilities"
        },
        {
          "id": 4,
          "text": "Subcentre has facility for diagnosis and treatment"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>District hospital</strong> has <strong>specialized facilities</strong> for the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (<strong>NPCDCS</strong>).</p>\n<p>The NPCDCS has separate components for cancer and other non-communicable diseases like diabetes, cardiovascular diseases, and stroke. It has been implemented in over 100 districts in 21 states.</p>\n<p>At the <strong>subcentre</strong> level under NPCDCS, <strong>screening</strong> <strong>and</strong> <strong>referral</strong> are done.</p>\n<p><strong>Note</strong>: The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke(<strong>NPCDCS</strong>) has been<strong> changed</strong> to the National Programme for Prevention and Control of Non-Communicable Diseases(<strong>NP-NCD</strong>) to include <strong>new diseases</strong> and new health initiatives.</p>\n<p>The new diseases included in the NP-NCD are:&nbsp;</p>\n<ul>\n<li>Non-alcoholic fatty liver disease</li>\n<li>Chronic Kidney disease</li>\n<li>Asthma and Chronic obstructive pulmonary disease</li>\n<li>ST elevation myocardial infarction</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c62eceb6cb6b4036a4fe5a120d247404x406x319.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8041",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a false statement about the Indian Hypertension Control Initiative (IHCI)?",
      "choices": [
        {
          "id": 1,
          "text": "The IHCI monitoring personnel includes cardiovascular health officers and senior treatment supervisors"
        },
        {
          "id": 2,
          "text": "Provision of real-time blood pressure monitoring for all patients via information systems"
        },
        {
          "id": 3,
          "text": "The IHCI provides 30-day medication for individuals registered for hypertension management"
        },
        {
          "id": 4,
          "text": "The target is a 90% reduction in the prevalence of hypertension by the year 2025"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The false statement about the Indian Hypertension Control Initiative is a 90% reduction in the prevalence of hypertension by the year 2025. </p>\n<p>The IHCI is an initiative by the <strong>MoHFW, WHO, ICMR, and state governments</strong> to control hypertension in India. It has adopted the goal of <strong>“25 by 25”</strong> to <strong>reduce the prevalence of hypertension</strong> in India <strong>by 25% by 2025</strong>. The activities of IHCI are monitored by the <strong>cardiovascular health officers (CVHO's)</strong> at the state and district level and by the <strong>senior treatment supervisors (STS's)</strong> at the sub-district level. The IHCI has strengthened the prevention of hypertension by ensuring the <strong>provision of antihypertensive medications</strong> for <strong>30 days</strong> to all patients registered under the IHCI.</p>\n<p>The 5 components of IHCI are:</p>\n<ol>\n<li aria-level=\"1\">Use of <strong>standardized hypertension treatment protocols</strong> approved by national and global policies.</li>\n<li aria-level=\"1\"><strong>Availability of recommended protocol drugs</strong> to provide a regular and uninterrupted supply of medications.</li>\n<li aria-level=\"1\"><strong>Task-sharing </strong>and<strong> team-based care</strong> involving nurses, health workers, and ASHAs to improve treatment compliance.</li>\n<li aria-level=\"1\"><strong>Patient-centered services</strong> provide easy access to BP monitoring at Health &amp; wellness centers and PHCs.</li>\n<li aria-level=\"1\"><strong>Information systems</strong> that provide real-time BP monitoring to improve patient follow-ups: Use of the <strong>“Simple App”</strong> in all IHCI states.</li>\n</ol>\n<p>*Note: Amlodipine, telmisartan, and chlorthalidone are the drugs of choice in the standardized treatment protocols of the IHCI.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7860",
      "difficulty": "medium"
    },
    {
      "text": "Under the National Programme for Control of Blindness & Visual Impairment, NGO eye hospitals are considered as:",
      "choices": [
        {
          "id": 1,
          "text": "Primary level centres"
        },
        {
          "id": 2,
          "text": "Secondary level centres"
        },
        {
          "id": 3,
          "text": "Tertiary level centres"
        },
        {
          "id": 4,
          "text": "Intermediate level centres"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>NGO eye hospitals are considered&nbsp;<strong>secondary level centres</strong> under the National Programme for Control of Blindness and Visual Impairment (NPCBVI).</p>\n<p><strong>Levels of eye care centres</strong> according to NPCBVI:</p>\n<ul>\n<li><strong>Primary</strong> level: Sub-district level hospitals, community health centres, mobile ophthalmic units, upgraded PHCs, and link workers.</li>\n<li><strong>Secondary</strong> level: District hospitals and <strong>NGO eye hospitals.</strong></li>\n<li><strong>Tertiary</strong> level: Regional institutes of ophthalmology and medical colleges.</li>\n</ul>\n<p>The goal of NPCBVI is to reduce the prevalence of blindness to 0.25% by 2025.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b365e6b64d624234a3fcafa66db8b2d2x378x378.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7980",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is used to measure the output of the National Programme for Control of Blindness & Visual Impairment?",
      "choices": [
        {
          "id": 1,
          "text": "Number of cases of refractory errors corrected"
        },
        {
          "id": 2,
          "text": "Number of cataract surgeries leading to sight restoration"
        },
        {
          "id": 3,
          "text": "Number of cases of childhood blindness detected and cured"
        },
        {
          "id": 4,
          "text": "Prevalence of blindness reduced by 0.5% per year"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The measure of the output of the National Programme for Control of Blindness &amp; Visual Impairment (NPCBVI) is indicated by the <strong>number of cataract surgeries leading to sight restoration.</strong>&nbsp;</p>\n<p>The most common cause of low vision in India is cataract (low vision is visual acuity &lt;6/18- 6/60).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4732",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following diseases is not a part of the Vision 2020 programme in India?",
      "choices": [
        {
          "id": 1,
          "text": "Refractive errors"
        },
        {
          "id": 2,
          "text": "Diabetic retinopathy"
        },
        {
          "id": 3,
          "text": "Corneal blindness"
        },
        {
          "id": 4,
          "text": "Onchocerciasis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Onchocerciasis is not a part of the Vision 2020 programme in India. It is a part of the Global Vision 2020 programme.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Global Vision 2020</strong></td>\n<td><strong>India Vision 2020</strong></td>\n</tr>\n<tr>\n<td>\n<p>Cataract</p>\n<p>Refractive errors and low vision</p>\n<p>Childhood blindness</p>\n<p><strong>Trachoma</strong></p>\n</td>\n<td>\n<p>Cataract</p>\n<p>Refractive errors and low vision</p>\n<p>Childhood blindness</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Onchocerciasis</strong></td>\n<td>Glaucoma</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Diabetic Retinopathy</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Corneal blindness</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4731",
      "difficulty": "easy"
    },
    {
      "text": "A pregnant woman from a rural area registers under Janani Suraksha Yojana. Which of the following services would not be provided to her under this scheme?",
      "choices": [
        {
          "id": 1,
          "text": "Safe motherhood services under Vandematharam scheme"
        },
        {
          "id": 2,
          "text": "Cash disbursement for institutional delivery"
        },
        {
          "id": 3,
          "text": "STD counseling"
        },
        {
          "id": 4,
          "text": "Safe abortion services"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The Janani Suraksha Yojana (JSY) does not provide STD counseling.</p>\n<p><strong>Janani Suraksha Yojana</strong>&nbsp;is a safe motherhood intervention launched under National Rural Health Mission (<strong>NRHM</strong>)<strong> to reduce maternal and neonatal mortality</strong> by promoting institutional delivery among poor pregnant women. The&nbsp;services provided by the JSY&nbsp;are:</p>\n<ul>\n<li><strong>Cash is disbursed</strong> to the mother at the institution for having an <strong>institutional</strong> <strong>delivery</strong>.</li>\n<li><strong>Safe motherhood services</strong> (IFA tablets, TT vaccination) under the&nbsp;<strong>Vandemataram scheme.&nbsp;</strong></li>\n<li>Village health and nutrition day</li>\n<li>Maternal death review</li>\n<li><strong>Pregnancy</strong> <strong>tracking</strong>:&nbsp;ASHA worker/Anganwadi Worker (AWW) or any other link worker help in monitoring antenatal check-ups, and post-delivery care.</li>\n<li><strong>Safe abortion services</strong>: mifepristone followed by misoprostol and manual vacuum aspiration.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3644",
      "difficulty": "medium"
    },
    {
      "text": "Where and how often is the Village Health Nutrition Day conducted?",
      "choices": [
        {
          "id": 1,
          "text": "Once a month in PHC"
        },
        {
          "id": 2,
          "text": "Once a month in Anganwadi"
        },
        {
          "id": 3,
          "text": "Once every two weeks in PHC"
        },
        {
          "id": 4,
          "text": "Once every two weeks in Anganwadi"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Village Health Nutrition Day is conducted&nbsp;<strong>once a month</strong> in the<strong> Anganwadi centres</strong> in the village itself. The villagers interact with health workers and are provided with basic services and information about health care.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4773",
      "difficulty": "medium"
    },
    {
      "text": "A 20-day old baby is gasping for air and not feeding properly. The mother has no money to go to the nearby hospital. Which national programme has provisions to benefit this woman to take her baby to the health facility?",
      "choices": [
        {
          "id": 1,
          "text": "Janani Suraksha Yojana"
        },
        {
          "id": 2,
          "text": "Rashtriya Bal Swasthya Karyakram"
        },
        {
          "id": 3,
          "text": "Janani Shishu Suraksha Karyakram"
        },
        {
          "id": 4,
          "text": "Navjaat Shishu Suraksha Karyakram"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The Janani Shishu Suraksha Karyakram&nbsp;(<strong>JSSK</strong>) has provisions for <strong>free transport</strong>&nbsp;of&nbsp;<strong>pregnant women </strong>and<strong> sick infants</strong> from:</p>\n<ul>\n<li>home to the health facilities</li>\n<li>between facilities in case of a referral</li>\n<li>back home from the health facilities</li>\n</ul>\n<p>The provisions of JSSK include:</p>\n<ul>\n<li>Free transport</li>\n<li>Free treatment</li>\n<li>Free drugs and consumables</li>\n<li>Free diagnostics and diet</li>\n<li>Free and cashless delivery</li>\n<li>Free C-Section</li>\n<li>Free provision of blood</li>\n</ul>\n<p>Note: Previously under JSSK, the free entitlements were provided only for sick newborns till 30 days after birth. Now it is expanded to cover <strong>infants</strong> also.</p><p>Assured&nbsp;<strong>18 service guarantees</strong>&nbsp;are provided to all pregnant women under&nbsp;<span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;May 28th has been commemorated as the International Day of Action for Women&rsquo;s Health, to create awareness regarding the sexual and reproductive health and rights of women worldwide.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33563519,&quot;3&quot;:{&quot;1&quot;:0},&quot;4&quot;:{&quot;1&quot;:2,&quot;2&quot;:6989903},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:0,&quot;11&quot;:4,&quot;12&quot;:0,&quot;16&quot;:10,&quot;28&quot;:1}\"><strong>Surakshit Matritva Aashwasan</strong>&nbsp;(SUMAN). It is a new initiative to provide assured, dignified, respectful, and quality healthcare&nbsp;<strong>at no cost</strong>&nbsp;and zero tolerance for denial of services for every woman and newborn visiting the public health facility. It aims to<strong>&nbsp;end all preventable maternal and newborn deaths</strong>,&nbsp;morbidities and provide a positive birthing experience.&nbsp;</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4735",
      "difficulty": "easy"
    },
    {
      "text": "The Navjat Shishu Suraksha Karyakram was designed for which of the following demographic groups?",
      "choices": [
        {
          "id": 1,
          "text": "Lactating mothers"
        },
        {
          "id": 2,
          "text": "Children"
        },
        {
          "id": 3,
          "text": "Health personnel"
        },
        {
          "id": 4,
          "text": "Pregnant women"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>Navjat Shishu Suraksha Karyakram</strong>&nbsp;(NSSK) was designed to train <strong>health personnel</strong> in basic <strong>newborn care</strong> and resuscitation.</p>\n<p>The training is aimed to improve the delivery of excellent newborn care at every point and is usually done for <strong>2</strong> <strong>days</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8043",
      "difficulty": "hard"
    },
    {
      "text": "A 10-year-old girl has just started menstruating. Under which of the following national programmes, she will be provided with a pack of sanitary napkins by the ASHA worker in her village?",
      "choices": [
        {
          "id": 1,
          "text": "Janani Suraksha Yojana"
        },
        {
          "id": 2,
          "text": "Rashtriya Kishor Swasthya Karyakram"
        },
        {
          "id": 3,
          "text": "Sukanya Samriddhi Yojana"
        },
        {
          "id": 4,
          "text": "Kishori Shakti Yojana"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The girl will be provided with a pack of 6 sanitary napkins for 6 Rupees (called <strong>Freedays</strong>) by the ASHA worker through the <strong>Menstrual Hygiene Scheme</strong> under the <strong>Rashtriya Kishor Swasthya Karyakram (RKSK).</strong></p>\n<p>RKSK focuses on:</p>\n<ul>\n<li>Development of adolescent population (10-19 years).</li>\n<li>Weekly Iron and Folic Acid supplementation (100mg Fe + 500 mcg Folic Acid)</li>\n<li>Menstrual hygiene: A&nbsp;pack of 6 sanitary napkins for 6 Rupees (called <strong>Freedays</strong>) by the ASHA.</li>\n<li>It also includes enhancement of mental health and prevention of substance abuse and violence.</li>\n</ul>\n<p><strong>Sukanya Samriddhi Yojana&nbsp;</strong>is a government-sponsored <strong>savings program</strong> for parents of girl children &lt;10 years age.&nbsp;It helps parents to set aside money for their female child&rsquo;s potential <strong>college and marriage expenses</strong> by opening an account at any post office branch or any commercial bank approved by the central government.</p>\n<p><strong>Kishori Shakti Yojana</strong> (KSY) seeks to <strong>empower adolescent girls</strong>, so as to enable them to take charge of their lives.&nbsp;The objectives are to:</p>\n<ul>\n<li>improve the nutritional, health and development status of adolescent girls</li>\n<li>promote awareness of health, hygiene, nutrition and family care</li>\n<li>opportunities for learning life skills</li>\n<li>going back to school</li>\n<li>help them gain a better understanding of their social environment</li>\n<li>take initiatives to become productive members of society.</li>\n</ul>\n<p><strong>Recent update:</strong>&nbsp;Department of Pharmaceuticals under Ministry of Chemicals and Fertilizers has recently launched<strong> &lsquo;Suvidha&rsquo;</strong>&nbsp;(<strong>100% Oxo-biodegradable Sanitary Napkin),</strong>&nbsp;under the <strong>Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) </strong>on World menstrual hygiene day.<strong>&nbsp;</strong>&lsquo;Swachhta, Swasthya and Suvidha&rsquo;&nbsp;will be available for Rs. 1 per pad over 3200 Janaushadhi Kendras for the underprivileged women of India.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/068ec92f207f4c09800d45bfaf47356cx188x269.PNG\" alt=\"Explanation Image\"><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;National Girld child day is observed on January 24th annually to raise awareness about the issues and challenges faced by the girl children in India and promote their rights and empowerment by eliminating gender biases, and emphasise the importance of education, health, and nutrition. &quot;}\" data-sheets-userformat=\"{&quot;2&quot;:829,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\"><strong>National Girl child day</strong> is observed on January 24th annually to raise awareness about the issues and challenges faced by the girl children in India and promote their rights and empowerment by eliminating gender biases, and emphasise the importance of education, health, and nutrition. </span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4734",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following is not true about POSHAN Abhiyan?",
      "choices": [
        {
          "id": 1,
          "text": "It is a programme of the Ministry of Women and Child Development"
        },
        {
          "id": 2,
          "text": "The goals are to achieve improvement in neonatal mortality"
        },
        {
          "id": 3,
          "text": "Launched on the date of International Women's Day 2018"
        },
        {
          "id": 4,
          "text": "Targets to reduce low birth weight by 2% per annum"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The goal of<strong> POSHAN</strong> Abhiyaan /National Nutrition Mission<strong> </strong>(<strong>NNM</strong>) is to achieve an improvement in<strong> </strong>the <strong>nutritional status </strong>during the next three years beginning 2017-18. It is a flagship programme of the Ministry of Women and Child Development (MWCD). Its <strong>target population</strong> include:</p>\n<ul>\n<li>children from 0-6 years</li>\n<li>adolescent girls</li>\n<li>pregnant women</li>\n<li>lactating mothers </li>\n</ul>\n<p>The logo is:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/96c51b486a8f4f7dbf96f966654d5432x257x196.PNG\" alt=\"Explanation Image\"><p>The following image depicts the targets of this mission:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/facf88750a1b46c4896bc72132703314x928x649.PNG\" alt=\"Explanation Image\"><p><strong>Note</strong>: <strong>Nikshay Poshan Yojana</strong> is a government scheme in India to provide <strong>Rs.500 per month</strong> for <strong>TB</strong> patients to buy food.</p>\n<p> </p><p>The <strong>National Nutrition Week</strong> is an annual event, observed from<strong> 1 to 7 September</strong> every year initiated by the Food and Nutrition Board. The main objective is to raise awareness on the importance of nutrition for health which has an impact on development, productivity, economic growth, and ultimately national development.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2844",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the objective of the Ujjawala Scheme?",
      "choices": [
        {
          "id": 1,
          "text": "Provide LPG connections to families below poverty line"
        },
        {
          "id": 2,
          "text": "Eliminate violence against children"
        },
        {
          "id": 3,
          "text": "Prevent trafficking"
        },
        {
          "id": 4,
          "text": "Provide LED bulbs in every household"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>Ujjawala Scheme</strong> is for the <strong>prevention of</strong> <strong>trafficking</strong> and for the rescue, rehabilitation, and reintegration of victims of trafficking for commercial sexual exploitation.</p>\n<p>The <strong>Ujjwala Yojana (note spelling without \"a\")</strong> is for providing 5 crores of free cooking <strong>LPG connections</strong> to all families below the poverty line till 2019.</p>\n<p>The <strong>Ujala Scheme</strong> (Unnat Jyoti by Affordable LEDs and Appliances for All) is the largest domestic lighting project in the world, launched under the Ministry of Power. It aims at promoting the use of <strong>energy-efficient LED bulbs</strong> in every household in the country.</p>\n<p><strong>INSPIRE </strong>strategy is a set of 7 evidence-based strategies introduced to select, implement, monitor, and evaluate effective policies, programs, and services to <strong>prevent</strong> and respond to <strong>violence against children.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4750",
      "difficulty": "medium"
    },
    {
      "text": "An ASHA worker is offering services under the Swachh Bharat Abhiyan in her village. All of the following services will be provided by her except:",
      "choices": [
        {
          "id": 1,
          "text": "Water pollution control"
        },
        {
          "id": 2,
          "text": "Solid waste management"
        },
        {
          "id": 3,
          "text": "Household toilets and public toilets"
        },
        {
          "id": 4,
          "text": "Information, education, communication and public awareness"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Water pollution is not managed under the Swachh Bharat Abhiyan.</p>\n<p>The Swachh Bharat Abhiyan was launched in 2014 with an&nbsp;aim to <strong>eradicate open-air defecation</strong> by the year 2019 through the construction of 12 million toilets. The two sub-missions of Swachh Bharat Abhiyan are <strong>Swachh Bharat Mission Gramin (SBM-G)</strong> and <strong>Swachh Bharat Mission Urban (SBM-U)</strong>.</p>\n<ul>\n<li><strong>Components</strong> of this mission include: <br />\n<ul>\n<li>Household toilets including improving unsanitary latrines</li>\n<li>Community toilets</li>\n<li>Public toilets</li>\n<li>Solid waste management</li>\n<li>Information, education, communication, and public awareness</li>\n<li>Capacity building and administrative &amp; office expenses</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8048",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about the Ayushman Bharat-National Health Protection Mission?",
      "choices": [
        {
          "id": 1,
          "text": "Government provides health insurance cover of up to Rs. 5,00,000 per family per year"
        },
        {
          "id": 2,
          "text": "The limit of the family size that is covered is up to 7 members"
        },
        {
          "id": 3,
          "text": "All pre-existing diseases of the individual are covered"
        },
        {
          "id": 4,
          "text": "It covers secondary and tertiary care hospitalization"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>There is<strong> no cap</strong> on family size or the age of the members. All the families listed under the Socio-Economic Caste Census (SECC) database are covered as per the defined criteria.</p>\n<p>The following are the benefits provided under this program:</p>\n<ul>\n<li>Health insurance cover of up to <strong>Rs. 5,00,000 per family per year.</strong></li>\n<li>All families listed in the SECC database, as per the defined criteria, will be covered. There is&nbsp;<strong>no cap on family size and age of members.</strong></li>\n<li><strong>Free treatment</strong> is available at<strong> all public and empanelled private hospitals</strong></li>\n<li>Both <strong>secondary and tertiary care </strong>hospitalization is covered.</li>\n<li>All <strong>pre-existing diseases </strong>are <strong>covered. </strong>Hospitals <strong>cannot deny treatment.</strong></li>\n<li>To control costs, the payments for treatment will be done on a package rate (to be defined by the Government in advance) basis.</li>\n<li>Cashless and paperless access to quality health care services.</li>\n</ul><p>Logo:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/abdb823c778f4f939f358d9f3f5ecdddx647x374.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ca7b32dbf41a439da3ebdc34be2d8613x680x365.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5275",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is true regarding Rajiv Gandhi Shramik Kalyan Yojana?",
      "choices": [
        {
          "id": 1,
          "text": "Unemployment allowance is not given in case of closure of factory"
        },
        {
          "id": 2,
          "text": "Unemployment allowance is given in case of employment injury"
        },
        {
          "id": 3,
          "text": "Allowance is given at 50% of the daily wage for a maximum of 2 years"
        },
        {
          "id": 4,
          "text": "To qualify for the scheme, worker must have worked for more than 2 years"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Unemployment allowance under Rajiv Gandhi Shramik Kalyan Yojana (RGSKY)<strong>&nbsp;</strong>is given at the rate of <strong>50% of daily wage</strong> for a maximum of <strong>2 years.</strong></p>\n<p>RGSKY is a scheme of ESI that provides <strong>u</strong><strong>nemployment allowance</strong>&nbsp;to an insured person going out of employment <strong>involuntarily</strong>, on account of:</p>\n<ul>\n<li><strong>closure</strong>&nbsp;of a factory or establishment&nbsp;</li>\n<li><strong>retrenchment</strong>&nbsp;(laying off employees due to economic difficulty)</li>\n<li><strong>permanent disability</strong>&nbsp;due to&nbsp;<strong>nonemployment</strong>&nbsp;injury</li>\n</ul>\n<p>Allowance and eligibility criteria of Rajiv Gandhi Shramik Kalyan Yojana (updated in 2019):</p>\n<ul>\n<li>The allowance is given at the rate of&nbsp;<strong>50% </strong>of the<strong> daily wage</strong>&nbsp;for a maximum of&nbsp;<strong>2 years.</strong></li>\n<li>To qualify for the scheme the worker&nbsp;must have worked in that setup for <strong>&gt;3 years</strong>.</li>\n</ul>\n<p><strong>Note:&nbsp;</strong>Disability due to<strong>&nbsp;employment injury&nbsp;</strong>is covered under disablement benefits of&nbsp;<strong>ESI Act, 1948.</strong></p>\n<ul>\n<li><strong>Temporary disability: 90%&nbsp;</strong>of&nbsp;wages until disablement lasts.</li>\n<li><strong>Permanent disability: 90%&nbsp;</strong>of wages as a&nbsp;<strong>life pension&nbsp;</strong>on the basis of loss of earning capacity.</li>\n<li><strong>Dependants benefit:</strong>&nbsp;<strong>90%&nbsp;</strong>of wage as monthly payment to the dependants of the deceased person, in cases where death occurs due to employment injury or occupational hazards.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4963",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following does the Laqshya initiative launched recently by the Government of India refer to?",
      "choices": [
        {
          "id": 1,
          "text": "Initiative for providing free sanitary pads"
        },
        {
          "id": 2,
          "text": "Initiative to provide vaccination to under-5 children"
        },
        {
          "id": 3,
          "text": "Initiative for labour room quality improvement"
        },
        {
          "id": 4,
          "text": "Initiative to provide affordable healthcare to all"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The Laqshya initiative launched recently by the Government of India refers to the initiative for<strong> labour room quality </strong>improvement.</p>\n<p>There is enough evidence to support the fact that improving the quality of care in labour rooms, especially on the day of birth, is crucial to maternal and neonatal survival.</p>\n<p><strong>Laqshya</strong> is expected to improve the quality of care being provided to the pregnant mother in the <strong>labour room </strong>and <strong>maternity operation theatres</strong>, thereby preventing the undesirable adverse outcomes associated with childbirth.&nbsp;This initiative is implemented in government medical colleges besides district hospitals, and high delivery load sub-district hospitals,&nbsp;and community health centres.</p>\n<p>It plans to conduct <strong>quality certification</strong> of labour rooms and also <strong>incentivize facilities</strong> achieving the targets outlined.&nbsp;The goal is to <strong>reduce preventable maternal and new-born mortality, morbidity,</strong> and <strong>stillbirths</strong> associated with the care around delivery in labour room and maternity OT, and ensure respectful maternity care.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2376",
      "difficulty": "easy"
    },
    {
      "text": "The image below shows the logo of which of the following national programmes?",
      "choices": [
        {
          "id": 1,
          "text": "Beti bachao, Beti padhao programme"
        },
        {
          "id": 2,
          "text": "India New Born Action Plan"
        },
        {
          "id": 3,
          "text": "Janani Shishu Suraksha Karyakram"
        },
        {
          "id": 4,
          "text": "Family Planning Campaign"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The image shown is the new logo of the 360-degree holistic <strong>Family Planning Campaign</strong>.</p>\n<p>Logo of other options:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1df31adbd0f847eebee49a689f1082adx291x277.PNG\" alt=\"Explanation Image\"><p>\"Beti bachao Beti padhao.\"</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/97f7c5d17d9240f8b3e9e9096c83af1fx260x229.PNG\" alt=\"Explanation Image\"><p>India Newborn Action Plan (INAP)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8999bde1e1d94870891948c1da345641x401x440.JPEG\" alt=\"Explanation Image\"><p>The logo of Janani Shishu Suraksha Karyakaram<strong>&nbsp;</strong>(JSSK)</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7e635c3bb208439da60e223729cfb243.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3833",
      "difficulty": "medium"
    },
    {
      "text": "What is the main objective of the Pradhan Mantri Bhartiya Jan-aushadhi Pariyojana?",
      "choices": [
        {
          "id": 1,
          "text": "Improve maternal and child health services"
        },
        {
          "id": 2,
          "text": "Make quality, generic medicines affordable to all"
        },
        {
          "id": 3,
          "text": "Enhance quality of life and increase employment for the differently abled"
        },
        {
          "id": 4,
          "text": "Promote cleanliness and enhance quality of healthcare facilities in India"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The&nbsp;<strong>Pradhan Mantri Bhartiya Jan-aushadhi Pariyojana (PMBJP)</strong> carries the objective of making<strong> quality, generic medicines affordable for everyone,</strong> especially the lower socio-economic groups.</p>\n<p><strong>BPPI </strong>(Bureau of Pharma PSUs of India), under the Ministry of Chemicals &amp; Fertilizers, is the implementation agency for PMBJP. The mission of this programme includes creating awareness and demand for generic medicines through education and supply of such medications.</p>\n<p><strong>Kayakalp</strong> programme is a<strong>&nbsp;</strong>national initiative launched by the Ministry of Health and Family Welfare (MoHFW) under Swachh Bharat Abhiyan to <strong>promote</strong> <strong>cleanliness</strong> and enhance the quality of healthcare facilities in India.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9d15b788f21c4d6090d9c167acab582bx153x127.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5970",
      "difficulty": "easy"
    },
    {
      "text": "The Mid Day Meal Programme aims to supplement:",
      "choices": [
        {
          "id": 1,
          "text": "1/2 protein and 1/3 calorie requirements"
        },
        {
          "id": 2,
          "text": "1/3 protein and 1/3 calorie requirements"
        },
        {
          "id": 3,
          "text": "1/2 protein and 1/2 calorie requirements"
        },
        {
          "id": 4,
          "text": "1/3 protein and 1/2 calorie requirements"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Under the<strong>&nbsp;Mid-Day Meal</strong>&nbsp;(MDM)&nbsp;<strong>scheme</strong>, supplementary nutrition provided must cover at least<strong>&nbsp;1/2 of total daily protein requirement and 1/3rd of total daily energy requirement</strong>&nbsp;of children in schools.</p>\n<p>The MDM scheme is also called&nbsp;<strong>School Lunch Programme</strong>&nbsp;and has been operational since 1961 in India. Currently, it functions under the broad coverage of the<strong>&nbsp;Minimum Needs Programme.</strong></p>\n<p>Some other principles of the MDM are:</p>\n<ul>\n<li>The meal provided under the MDM should only be a&nbsp;<strong>supplement</strong>&nbsp;and not a substitute for home diets.</li>\n<li>The<strong>&nbsp;cost </strong>of meals should be <strong>reasonably low.</strong></li>\n<li>The meal should be&nbsp;<strong>easy to cook</strong>&nbsp;in schools.</li>\n<li><strong>Locally available foods</strong>&nbsp;must be used, for as far as possible.</li>\n<li>The menu should be&nbsp;<strong>regularly changed</strong>&nbsp;to avoid monotony.</li>\n</ul>\n<p>Note: In September 2021, the Mid-Day Meal Scheme was renamed <strong>PM POSHAN</strong>&nbsp;or Pradhan Mantri Poshan Shakti Nirman.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7002",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is not true regarding the Vandematharam scheme?",
      "choices": [
        {
          "id": 1,
          "text": "Free treatment in private clinics"
        },
        {
          "id": 2,
          "text": "Its aim is to provide safe motherhood services"
        },
        {
          "id": 3,
          "text": "An MBBS graduate or an obstetrician can volunteer"
        },
        {
          "id": 4,
          "text": "IFA tablets and TT injections are provided by District Medical Officers"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The Vandematharam&nbsp;scheme&nbsp;does not include free treatment in private clinics.</p>\n<p><strong>Vandematharam</strong> scheme is a <strong>voluntary</strong> scheme for providing<strong> safe motherhood services</strong>. It can be volunteered by an obstetrician, maternity home, nursing home, lady doctor or an MBBS graduate.</p>\n<p><strong>IFA</strong> tablets, <strong>OCPs</strong>, and <strong>TT</strong> <strong>injections</strong> are provided by the respective District Medical Officers (<strong>DMOs</strong>) to the&nbsp;Vandematharam&nbsp;doctors or clinics&nbsp;for free distribution to beneficiaries. Cases needing special care and treatment can be referred to government hospitals.</p><p>11th of April is being observed as the National Safe Motherhood Day in India.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3599",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a component of the scheme depicted by the logo given below?",
      "choices": [
        {
          "id": 1,
          "text": "National Health Protection Mission"
        },
        {
          "id": 2,
          "text": "Pradhan Mantri Surakshit Matritva Abhiyaan"
        },
        {
          "id": 3,
          "text": "National Programme for Family Planning"
        },
        {
          "id": 4,
          "text": "National Rural Health Mission"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>National Health Protection Mission</strong> is a component of the Ayushman Bharat scheme.</p>\n<p>Ayushman Bharat-National Health Protection Mission (<strong>AB-NHPM</strong>)&nbsp;aims to build a comprehensive need-based health care service and targets&nbsp;to build a '<strong>New</strong> <strong>India 2022'</strong>. Its components are:</p>\n<ul>\n<li>Creation of 1,50,000&nbsp;<strong>Health and Wellness Centres- </strong>these centres will provide Comprehensive Primary Health Care (CPHC), covering both maternal and child health services and non-communicable diseases, including free essential drugs and diagnostic services.&nbsp;</li>\n<li><strong>National Health Protection Mission (NHPM)&nbsp;</strong>provides health protection cover to poor and vulnerable families, screening for non-communicable diseases, and follow-up of hospitalization cases among others.</li>\n</ul>\n<h3><strong>Beneficiary Level:&nbsp;</strong></h3>\n<ul>\n<li>The government provides health insurance cover of up to <strong>Rs. 5,00,000 per family per year.</strong></li>\n<li>All families listed in the Socio-Economic Caste Census (SECC) database as per defined criteria will be covered. <strong>No cap on family size and age of members.</strong></li>\n<li>Priority to a girl child, women, and senior citizens.</li>\n<li><strong>Free treatment</strong> is available at<strong> all public and empanelled private hospitals </strong>in times of need.</li>\n<li>Covers <strong>secondary and tertiary care </strong>hospitalization.</li>\n<li>1,350 medical packages covering surgery, medical and daycare treatments, cost of medicines, and diagnostics.</li>\n<li>All <strong>pre-existing diseases </strong>are <strong>covered. </strong>Hospitals <strong>cannot deny treatment.</strong></li>\n<li>Cashless and paperless access to quality health care services.</li>\n<li>Hospitals will not be allowed to charge any additional money from beneficiaries for the treatment.</li>\n<li>Can reach out for information, assistance, complaints, and grievances to a 24X7 helpline number.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2c91218fbfc947b5b10d7bc5c40d6599x814x470.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a35c805d486404dba97c8ff60f2c680x720x386.JPEG\" alt=\"Explanation Image\"><p>Ayushman Bharat Diwas is being celebrated across the country on April 30.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c0fe8156b53b457a97272c41bdb9eb95.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6578",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following vaccines has not been introduced to the immunization programme in India?",
      "choices": [
        {
          "id": 1,
          "text": "Adult Japanese encephalitis"
        },
        {
          "id": 2,
          "text": "Influenza"
        },
        {
          "id": 3,
          "text": "Measles-Rubella"
        },
        {
          "id": 4,
          "text": "Rotavirus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Influenza vaccine (Flu shot) has not been introduced to the National Immunization Programme in India. </p>\n<p>The Influenza vaccine provides protection against <strong>viral flu</strong> caused by the <strong>influenza virus</strong>.</p>\n<p>Note: <strong>Bacterial</strong> Hemophilus influenzae type-b <strong>(Hib)</strong> vaccine is different from the <strong>viral</strong> influenza <strong>(Flu)</strong> vaccine. HiB is a part of the pentavalent vaccine.</p><p><strong>World Immunization Week</strong> is celebrated in the <strong>last week of April</strong>.</p>\n<p>The theme of the <strong>2022</strong> campaign was '<strong>Long Life for All'.</strong></p>\n<p>The theme of the <strong>2023</strong> campaign is<strong> 'The Big Catch-Up'.</strong></p>\n<p>The theme of<strong> 2024</strong> campaign is<strong> \"Humanly Possible: Immunization for All\".</strong></p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7000",
      "difficulty": "medium"
    },
    {
      "text": "The POCSO Act is related to which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Women empowerment"
        },
        {
          "id": 2,
          "text": "Human trafficking"
        },
        {
          "id": 3,
          "text": "Juvenile delinquency"
        },
        {
          "id": 4,
          "text": "Child sexual abuse"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The POCSO (Protection of Children from Sexual Offences) Act is related to <strong>child sexual abuse.</strong></p>\n<p>POCSO Act defines a child as any person <strong>below eighteen years </strong>of age. It defines different forms of sexual abuse, including <strong>penetrative</strong> and <strong>non-penetrative</strong> <strong>assault</strong>, as well as <strong>sexual harassment</strong> and <strong>pornography</strong>.</p>\n<p>The Act deems a sexual assault to be \"<strong>aggravated\"</strong>&nbsp;under certain circumstances, such as when the abused child is <strong>mentally ill</strong> or when the abuse is committed <strong>by a person in a position of trust or authority</strong> vis-&agrave;-vis the child, like a family member, police officer, teacher, or doctor.</p>\n<p>People who <strong>traffic children</strong> for sexual purposes are also punishable under the provisions relating to abetment in the Act.&nbsp;The Act prescribes stringent punishment graded as per the gravity of the offence, with a maximum term of rigorous imprisonment for life and a fine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7011",
      "difficulty": "easy"
    },
    {
      "text": "Mass drug administration is not done for which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Worm infestation"
        },
        {
          "id": 2,
          "text": "Vitamin A deficiency"
        },
        {
          "id": 3,
          "text": "Scabies"
        },
        {
          "id": 4,
          "text": "Filariasis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Mass drug administration is not done in case of&nbsp;vitamin A deficiency.&nbsp;</p>\n<p>Mass Drug Administration (<strong>MDA</strong>) is the administration of a drug to an entire <strong>concerned population irrespective of age and gender</strong>. For example, antimalarials are given as MDA in malaria-endemic island communities and in low-endemic non-island settings approaching elimination, where there is minimal risk of re-introduction of infection, good access to treatment, and implementation of vector control and surveillance.</p>\n<p><strong>Vitamin A </strong>prophylaxis is given under National Immunization Schedule (NIS) <strong>only</strong> to children <strong>up to 5 years.</strong> It is given as <strong>mass prophylaxis</strong> and <strong>not</strong> as a drug<strong> for treatment.</strong> Vitamin A as a treatment is given only to a child with features of vitamin A deficiency and such doses are not instituted to everyone in the community. Therefore, it is not considered under MDA.</p>\n<p>On the other hand, MDA is done in scabies (ivermectin), worm infestation (albendazole), and filariasis (DEC + albendazole).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0181",
      "difficulty": "hard"
    },
    {
      "text": "Monetary benefit is measured in which of the following analyses?",
      "choices": [
        {
          "id": 1,
          "text": "Cost effective analysis"
        },
        {
          "id": 2,
          "text": "Cost benefit analysis"
        },
        {
          "id": 3,
          "text": "Network analysis"
        },
        {
          "id": 4,
          "text": "Input Output analysis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The monetary benefit is measured in a&nbsp;<strong>cost-benefit analysis</strong>.</p>\n<p>In<strong>&nbsp;cost-benefit analysis,&nbsp;</strong>the <strong>economic benefits</strong> of any program are compared with the cost of the program. The benefits are expressed in monetary terms to determine whether a given programme is economically sound and to select the best out of several alternate programmes.</p>\n<p>The main&nbsp;drawback<strong>&nbsp;</strong>with this technique is that the benefits in the health field, as a result of a particular programme,&nbsp;cannot always&nbsp;be expressed in monetary terms. We generally express the benefit in terms of births or deaths prevented, or illness avoided or overcome.</p>\n<p>In<strong> cost-effective analysis</strong>, the benefit is expressed in terms of <strong>results achieved</strong>. (Eg: number of lives saved or number of days free from disease).</p>\n<p><strong>Input-output analysis</strong>: how much input is needed to produce a unit amount of output. In the health field, <strong>input</strong> refers to all health service activities which consume resources (manpower, money, materials, and time); and <strong>output</strong> refers to useful outcomes such as cases treated, lives saved, or inoculations performed.</p>\n<p><strong>Network analysis: </strong>a&nbsp;network is a graphic plan of all events and activities to be completed in order to reach an end objective.</p>\n<p><strong class=\"ng-binding\">Management Methods in Health Programmes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Methods based on behavioral sciences</strong></p>\n</td>\n<td>\n<p><strong>Quantitative methods</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Organisational design</p>\n<p>Personnel management</p>\n<p>Communication</p>\n<p>Information systems</p>\n<p>Management by objectives (MBO)</p>\n</td>\n<td>\n<p>Cost&ndash;Benefit analysis</p>\n<p>Cost-Effective analysis</p>\n<p>Cost&ndash;Accounting</p>\n<p>Input&ndash;Output analysis</p>\n<p>Model</p>\n<p>Systems analysis</p>\n<p>Network analysis- Includes Programme Evaluation and Review Technique (PERT) and Critical Path Method (CPM)</p>\n<p>Planning&ndash;Programming&ndash;Budgeting System (PPBS)</p>\n<p>Work sampling</p>\n<p>Decision making</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"panel-body ng-scope\">&nbsp;</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0721",
      "difficulty": "easy"
    },
    {
      "text": "As per NCEP- ATP III, which of the following is not a criterion for metabolic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Hypertriglyceridemia"
        },
        {
          "id": 2,
          "text": "High LDL"
        },
        {
          "id": 3,
          "text": "Central obesity"
        },
        {
          "id": 4,
          "text": "Hypertension"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>As per NCEP- ATP III, high LDL is not included in the definition criteria of metabolic syndrome.</p>\n<p><strong>Metabolic syndrome</strong> is present if <strong>three or more</strong> of the following five criteria are met, which is given by NCEP-ATP III (National Cholesterol Education Program and Adult Treatment Panel III). It includes:</p>\n<ul>\n<li><strong>Central obesity</strong>: waist circumference &gt;102 cm (M), &gt;88 cm (F)</li>\n<li><strong>Hypertriglyceridemia</strong>: triglyceride level ≥ 150 mg/dL</li>\n<li><strong>Low HDL</strong> cholesterol: &lt;40 mg/dL and &lt;50 mg/dL for men and women, respectively.</li>\n<li><strong>Hypertension</strong>: blood pressure ≥130 mmHg systolic or ≥ 85 mmHg diastolic.</li>\n<li><strong>Fasting plasma glucose level</strong>: ≥100 mg/dL or previously diagnosed type 2 diabetes.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3076",
      "difficulty": "medium"
    },
    {
      "text": "In Sustainable Development Goal 3, the target 3.1 aims to reduce the Maternal Mortality Ratio by 2030 to ____ (per 1 lakh live births):",
      "choices": [
        {
          "id": 1,
          "text": "<70"
        },
        {
          "id": 2,
          "text": "<100"
        },
        {
          "id": 3,
          "text": "<50"
        },
        {
          "id": 4,
          "text": "<130"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In Sustainable Development Goal 3, the target 3.1 aims to reduce the Maternal Mortality Ratio by 2030 to&nbsp;<strong>&lt;70&nbsp;per 1 lakh live births</strong>.</p>\n<p>There are <strong>17 global goals</strong> and 169 targets set for <strong>2030</strong> as part of the official <strong>Sustainable Development Goals </strong>of the <strong>Agenda 2030.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4d001dce90e2480f9b10d26c16d93dd1x1280x816.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0718",
      "difficulty": "medium"
    },
    {
      "text": "As per the new National Policy for Rare Diseases, financial support of up to Rs. 20 lakhs can be given to which group of rare diseases?",
      "choices": [
        {
          "id": 1,
          "text": "Group 1"
        },
        {
          "id": 2,
          "text": "Group 2"
        },
        {
          "id": 3,
          "text": "Group 3"
        },
        {
          "id": 4,
          "text": "Group 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>As per the new National Policy for Rare Diseases, a provision for financial support of up to <strong>Rs.</strong>&nbsp;<strong>20 lakhs</strong>&nbsp;under the umbrella scheme of <strong>Rashtriya Arogya Nidhi</strong>&nbsp;is proposed for the treatment of rare diseases that require a <strong>one-time treatment</strong> (listed under <strong>Group 1</strong> in the rare disease policy).&nbsp;</p>\n<p>National Policy for Rare Diseases is a comprehensive policy for the prevention and management of rare diseases. The policy lists rare diseases under <strong>3 groups:</strong></p>\n<ul>\n<li><strong>Group 1: </strong>Disorders amenable to<strong> one-time curative treatment:</strong>\n<ul>\n<li>Disorders amenable to hematopoietic stem cell transplantation eg: lysosomal storage disorders</li>\n<li>Disorders amenable to organ transplantation eg: glycogen storage disorders, urea cycle disorders, ADPKD, etc.</li>\n</ul>\n</li>\n<li><strong>Group 2: </strong>Diseases requiring<strong> long term/ lifelong treatment </strong>having a <strong>relatively lower cost </strong>of treatment:\n<ul>\n<li>This group includes disorders managed with special dietary formulae/ hormone/ specific drugs. eg: phenylketonuria, osteogenesis imperfecta, etc.</li>\n</ul>\n</li>\n<li><strong>Group 3: </strong>Diseases for which <strong>definitive treatment</strong> is available but treatment is <strong>lifelong or expensive:</strong>\n<ul>\n<li>This group includes diseases such as Pompe disease, Duchenne muscular dystrophy, etc.</li>\n</ul>\n</li>\n</ul>\n<p>The <strong>objectives</strong> of the policy are:</p>\n<ul>\n<li aria-level=\"1\">Lowering the high cost of treatment for rare diseases with an increased focus on indigenous research.</li>\n<li aria-level=\"1\">Creating a national hospital-based registry of rare diseases.&nbsp;</li>\n<li aria-level=\"1\">Early screening and prevention through primary and secondary health care infrastructure, and through counselling for the high-risk parents.</li>\n<li aria-level=\"1\">Crowdfunding mechanism in which corporates and individuals will be encouraged to extend financial support.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME1154",
      "difficulty": "hard"
    },
    {
      "text": "You are a medical officer at a PHC. Which of the following would you advise for mass prophylaxis/ treatment for anemia?",
      "choices": [
        {
          "id": 1,
          "text": "FeSO4 + Vit C + Folate + Vit B12"
        },
        {
          "id": 2,
          "text": "Iron (III) hydroxide polymaltose"
        },
        {
          "id": 3,
          "text": "Ferrous fumarate"
        },
        {
          "id": 4,
          "text": "Inj. iron sucrose"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Among the given options, <strong>FeSO4 + vitamin C + Folate + vitamin B12</strong> may be considered for <strong>mass prophylaxis</strong> against anemia.</p>\n<p><strong>Vit C</strong> <strong>enhances</strong> the <strong>absorption</strong> <strong>of</strong> <strong>iron</strong> from the stomach by acting as a reducing substance.&nbsp;</p>\n<p><strong>Subclinical folate deficiency</strong> is seen in up to 30% of North Indian pregnant women. Moreover, it may be masked by widespread iron deficiency. It is, for this reason, iron and folate supplementation is carried out in national programmes.&nbsp;</p>\n<p>Clinical vitamin B12 deficiency is not commonly encountered, but subclinical cases might be seen in up to 30% of adults and children due to widespread restriction to consumption of vegetarian products only. Hence supplementing vitamin B12 is a good idea provided the cost factor is not an issue.</p>\n<p>Option B: Iron (III) hydroxide polymaltose was marketed as being superior to iron sulfate in terms of efficacy, but it lacked any data to back up the evidence.</p>\n<p>Option C: Ferrous fumarate may be considered for the treatment of iron deficiency anemia with similar efficacy as that of ferrous sulfate.</p>\n<p>Option D: Injection iron sucrose or any parenteral form is not used as a first-line option. It is only indicated if the oral form is not tolerated.</p><hr><h3>Related Pearl: Prophylactic Iron and Folic Acid (IFA) Supplementation</h3><p>According to the&nbsp;<strong>Anemia Mukt Bharat 2018 scheme,</strong>&nbsp;giving<strong> IFA</strong> to children, adolescents, women of reproductive age, and pregnant women,&nbsp;irrespective of their anemia status, is a key intervention.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age group</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Frequency</strong></td>\n<td><strong>Tablet Color</strong></td>\n</tr>\n<tr>\n<td><span>Children</span><br /><span>6-59 months of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 mL iron and folic acid syrup</p>\n<p>Each mL contains&nbsp;<strong>20 mg</strong> elemental<strong> iron </strong>+<strong> 100 mcg</strong> of<strong> folic&nbsp;acid</strong></p>\n</td>\n<td>\n<p>Bi-weekly</p>\n</td>\n<td>&nbsp;Syrup</td>\n</tr>\n<tr>\n<td><span>Children </span><br /><span>5-9 years of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 Iron and folic&nbsp;acid tablet</p>\n<p><strong>45 mg</strong> elemental iron +<strong> 400 mcg</strong> folic acid,</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Pink</td>\n</tr>\n<tr>\n<td>\n<p><span>School-going adolescent girls and Boys</span><br /><span>10-19 years of age</span></p>\n<p><span>Out-of-school adolescent girls</span><br /><span>10-19 years of age</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60&nbsp;mg&nbsp;</strong>elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Blue</td>\n</tr>\n<tr>\n<td>\n<p><span>Women of reproductive age (non-pregnant, non-lactating) </span><br /><span>20-49 years</span></p>\n<p><span>(Under Mission Parivar Vikas)</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60</strong>&nbsp;<strong>mg</strong> elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated&nbsp;</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Red</td>\n</tr>\n<tr>\n<td><span>Pregnant Women and Lactating Mothers </span><br /><span>of 0-6 months child</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet starting from the <strong>fourth month</strong> of pregnancy is continued throughout pregnancy (minimum 180 days). It should also be continued for 180 days post-partum.</p>\n<p><strong>60</strong>&nbsp;<strong>mg </strong>elemental iron +<strong> 500 mcg </strong>folic acid,</p>\n<p>Sugar-coated and red color</p>\n</td>\n<td>Daily&nbsp;</td>\n<td>Red&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note 1:<strong> Prophylaxis with iron</strong> should be <strong>withheld</strong> in case of <strong>acute illness</strong> (fever, diarrhea, pneumonia, etc.) and in a known case of <strong>thalassemia major</strong>/ history of <strong>repeated blood transfusion</strong>. In cases of children with severe acute malnutrition (SAM), IFA supplementation should be continued as per the SAM management protocol.</p>\n<p>Note 2: All women in the reproductive age group in the pre-conception period and up to the first trimester of the pregnancy are advised to have 400 mcg of folic acid tablets, daily, to reduce the incidence of neural tube defects in the fetus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6687",
      "difficulty": "easy"
    }
  ]
}